Experimental and computational assessment of mycosynthesized CdO nanoparticles towards biomedical applications.
The present study reports the biogenic synthesis of Cadmium Oxide Nanoparticles (CdO NPs) using plant pathogenic fungus Nigrospora oryzae culture filtrate. Further, the effect of the NPs on the cancer cell line (HeLa) is explored. The sample was characterized using Thermogravimetric/Differential Thermal (TG/DTA), Powder X-ray Diffraction (XRD), X-ray Photoelectron spectroscopy (XPS), UV-Visible Diffuse Reflectance Spectroscopy (UV-DRS), Field Emission Transmission Electron Microscopy (FE-SEM) with Energy Dispersive X-ray Spectroscopy (EDX), High Resolution Transmission Electron Microscopy (HR-TEM) and Selected Area Electron Diffraction (SAED) analysis. Antibacterial activity was evaluated against both Gram positive and Gram negative bacterial strains and it showed maximum activity against Proteus vulgaris. The larvicidal activity was performed to evaluate the maximum ability of synthesized CdO NPs against Anopheles stephensi. Subsequently, MTT assay also depicted the dose-dependent anticancer activity of CdO NPs against cancer cell line (HeLa). Additionally, the inhibitory effect of CdO NPs was analyzed through extensive docking with cancerous protein agent. Results enlighten that Transketolase protein exhibited high docking score of -4.8 k/mol with H-bond interactions found with Lys75 and Asn185 amino acid residues. DFT study was performed on CdO to understand the charge transfer reaction for the inhibitory mechanism. Convincingly, this study explores the understanding of CdO NPs against HeLa cells.